The company noted it reduced the list price of Symbicort at the start of this year. The change comes amid increasing attention and criticism about the cost of inhalers. The four major ...
Meanwhile, AstraZeneca's price cap will apply to the company's entire range of inhaler products used to treat asthma and COPD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback